🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, controlled clinical trial based on prior exploratory ...
Status
Not Yet Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2027-01-01
Trial ID
NCT07686796
Treatments Being Tested
This is a phase II open-label study to evaluate the efficacy and safety of ...
Status
Not Yet Recruiting
Location
Xijing Hospital, Air Force Medical University
Start Date
2026-07
Trial ID
NCT07685704
Treatments Being Tested
This study is a randomized, controlled, open-label phase III clinical trial...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-26
Trial ID
NCT07677293
This multicenter, randomized, open-label, blinded-endpoint Phase II trial a...
Status
Recruiting
Location
Daping Hospital Third Military Medical University, chongqing, chongqing 400000 Recruiting
Start Date
2026-04-10
Trial ID
NCT07468630
Treatments Being Tested
This study is a multicenter, randomized, open-label, controlled Phase III c...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-05-28
Trial ID
NCT07584135
The purpose of this study is to assess the efficacy and safety of QL1706 in...
Status
Not Yet Recruiting
Location
Nanjing Tianyinshan Hospital
Start Date
2023-09-01
Trial ID
NCT05976568
Treatments Being Tested
Sintilimab (R\&D code: IBI308) is a recombinant human-derived IgG4 type PD-...
Status
Active Not Recruiting
Location
Xuefeng Fang
Start Date
2022-02-08
Trial ID
NCT05171660
Treatments Being Tested
This study was a prospective, single-arm, multi-center, phase Ⅱ clinical st...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-15
Trial ID
NCT07638631
Treatments Being Tested
The purpose of this study is to acssess the efficacy and the safety of Sint...
Status
Unknown
Location
Yang Jianjun
Start Date
2022-05-01
Trial ID
NCT05544812
Treatments Being Tested
Alpha-fetoprotein-producing gastric cancer (AFP-positive gastric cancer, AF...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07515625
Treatments Being Tested